An observational study in Pneumonia, sponsored by Chongqing Medical University. Completed at 1 site in China. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-23.
Sponsored by Chongqing Medical University · Observational
To identifying biomarkers in patients with pneumonia
The aim of this study is to identify the biomarkers in patients with pneumonia. These biomarkers can distinguish community-acquired pneumonia, hospital-acquired pneumonia, severe pneumonia, bacterial infection, virus infection and fungal infection. Furthermore, these biomarkers can identify the efficacy of treatment in patients with different interventions.
2,044 studies on the registry are indexed under Pneumonia; 283 are open to participants now.
This study's enrollment of 272 is above the median of 203 across 688 observational studies indexed under Pneumonia.
Browse Pneumonia studies →Chongqing Medical University is the lead sponsor of 75 studies on the registry; 17 are open to participants now.
Counted across the registry records on this site, refreshed daily.
patients with pneumonia
Inclusion Criteria: Healthy patients without any diseases -
Exclusion Criteria:Age less than 18 years
-
mortality
Mortality is defined the patient died in hospital.
Time frame: From diagnosis of pneumonia to discharge from hospital or up to 90 days, whichever came first
severe pneumonia
The pneumonia deteriorated and reached the criteria of severe pneumonia. Severe pneumonia was diagnosed according to the guideline published by ATS.
Time frame: From diagnosis of pneumonia to discharge from hospital or up to 90 days, whichever came first
initial treatment failure
Initial treatment failure means the patients' condition progressively deteriorated although comprehensive treatment was administrated. As a result, the treatment should be changed or the patient required admission to ICU.
Time frame: From diagnosis of pneumonia to discharge from hospital or up to 90 days, whichever came first
Plan to share: Undecided — Data sharement should be contact with us.
No publications or documents are linked to this record.
This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Chongqing Medical University